David Icke - Infowars Election Coverage 2012
Alex Jones talks with author and presenter David Icke about election fraud and human genetics. http://www.davidicke.com http://www.infowars.com prisonplanet.tv conspiracyscope.blogspot.com http://www.youtube.comFrom:ConspiracyScopeViews:518 13ratingsTime:58:00More inNews Politics
Read more:
David Icke Exposes ROYAL PAEDOPHILES
Alex talks with author and presenter David Icke about election fraud and human genetics. .From:sswemmerViews:17 2ratingsTime:58:00More inEducation
The rest is here:
REDWOOD CITY, Calif., Nov. 6, 2012 /PRNewswire/ --Ingenuity Systems, a leading provider of biomedical information and analysis solutions, today highlighted strong adoption of its Variant Analysis platform at the American Society of Human Genetics Annual Meeting in San Francisco. Variant Analysis, a web-based analysis application, answers a critical need for researchers trying to rapidly identify relevant casual variants in human diseases from re-sequencing data.
Over the past 6 months the number of users and samples uploaded into Ingenuity Variant Analysis has grown 250% month-over-month and today 1,100 users are actively working on whole genome and exome projects ranging from individual genomes to thousands of genomes. The users represent over 500 leading institutions and drug discovery companies studying all stages of basic, translational and clinical research.
"All of us need help interpreting DNA sequence variation in the context of the world's literature and rapidly evolving databases," said David M. Margulies, MD, Executive Director, Gene Partnership, Children's Hospital Boston and member of Faculties of Genetics, Bioinformatics, and Developmental Medicine, Harvard Medical School. "Ingenuity's rigorous methods for curating variant information and its deep capabilities in relating sequence and expression data to underlying pathways are invaluable to us as we seek to understand the contribution of sequence variation to disease in both clinical and discovery scenarios."
"The interpretation of human genomes for medical and biological relevance is a major challenge. Variant Analysis has proven to be a helpful tool to contribute to the interpretation of our exome sequencing-basedstudies," stated Estelle Chanudet-van den Brink, PhD, Senior Research Associate, GOSgene, University College of London. "We tested it in the context of 9 different rare genetic conditions (73 samples total), including variousmodes of inheritance.We found the process intuitive and the analytic parameters pragmatically fitted to the diversity of our data. The access to rich biological content, that leverages information on pathways and disease models, was particularly useful to support the prioritization of variants for further analyses.We are now extending the use of Variant Analysis to additional cohorts of patients (250 samples)."
"Increasing access to the unique content and intuitive graphical user interface in Variant Analysis allowed us to quickly identify variants of interest in our sequencing data on muscular dystrophy," said Susan Dorsey, PhD, RN, FAAN, Associate Dean for Research, University of Maryland."In a matter of hours, we were able to quickly learn how to use the tool and obtain preliminary results.I anticipate that we will be working with the company and its tools for years to come."
Further, at ASHG this week in San Francisco, attendees will have will have the opportunity to demo Variant Analysis in the Ingenuity booth #1101 or through its integration into third-party applications such as Ion Torrent's Ion Reporter and Illumina's BaseSpace.
About Ingenuity SystemsIngenuity Systems is a leading provider of biomedical information and analysis solutionsfor the exploration, interpretation and analysis of complex biological systems inlife science research and molecular diagnostics.Today, Ingenuity's solutions are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide.
Go here to see the original:
Ingenuity Variant Analysis Sees Exponential Customer Adoption
SAN JOSE, Calif., Nov. 5, 2012 /PRNewswire/ -- Ariosa Diagnostics today announced that it will present data from two recent studies on non-invasive prenatal testing (NIPT) at the American Society of Human Genetics (ASHG) Annual Meeting at The Moscone Center in San Francisco, Calif. from Nov. 6 - 11, 2012. The studies highlight a directed cell-free (cfDNA) analysis method of NIPT.
(Logo: http://photos.prnewswire.com/prnh/20121105/NE05794LOGO)
A poster titled "Non-invasive Chromosomal Evaluation (NICE) Study: Results of a Multicenter, Prospective, Cohort Study for Detection of Fetal Trisomy 21 and Trisomy 18," examines the performance of Ariosa's Harmony Prenatal Test, a directed cfDNA analysis method of detecting fetal trisomies. The NICE study represents the largest cohort study in NIPT. Pregnant women at gestational age 10 weeks or later were enrolled from 50 clinical sites in the U.S. and Europe. The poster will be presented on Thursday, Nov. 8, from 3:15 - 4:15 p.m. PST in The Moscone Center Exhibit Hall, Lower Level South.
A second poster titled "The Fetal Fraction of cell-free DNA in Maternal Plasma is Not Affected by a priori Risk of Fetal Trisomy," examines possible clinical factors that might influence the fetal fraction of cfDNA in maternal plasma. The amount of fetal cfDNA in maternal plasma is a major determinant of the ability to detect trisomy. A comparative analysis shows no difference in fetal cfDNA levels between high- and low-risk pregnant women providing support that NIPT performance will be just as robust in a general pregnancy population. This poster will be presented on Thursday, Nov. 8, from 3:15 - 4:15 p.m. PST in The Moscone Center Exhibit Hall, Lower Level South.
For more information about Ariosa and the company's directed cfDNA analysis method of NIPT, please visit us at Booth #1609.
About Ariosa Diagnostics
Ariosa Diagnostics, Inc., is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.
The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visitwww.ariosadx.com.
Continued here:
Public release date: 6-Nov-2012 [ | E-mail | Share ]
Contact: Cathy Yarbrough sciencematter@yahoo.com 858-243-1814 American Society of Human Genetics
A presentation at the American Society of Human Genetics 2012 meeting updated genetics experts about a one-year-old research initiative that brought together researchers, clinicians and policy experts to tackle the challenges of incorporating new genomic technologies into clinical care of newborns, infants and children with anatomical defects whose causes are unknown.
Among the challenges is interpreting how variations in patients' DNA cause or contribute to their medical problems, said Duke University Assistant Professor of Pediatrics Erica E. Davis, Ph.D., who presented the update and is based in the Center for Human Disease Modeling in the university's medical center.
In 2011, the center founded the Duke Task Force for Neonatal Genomics to act as a nucleus for a group of physicians and scientists with the diverse skills sets needed to bridge genetics, genomics, cell biology, ethics and clinical investigation and to offer a "360 degree" view of challenging clinical pediatric cases, Dr. Davis said.
"Strikingly, preliminary analysis of the task force's first year of work has suggested definitive or strong candidate diagnoses in some 90% of the recruited cases," she noted.
During its first year, the task force screened over 150 newborns, infants and children, enrolled 20 patients and developed the capacity to enroll about 100 patients each year.
"Our patients come from the Duke fetal diagnostic center, the Duke intensive care nursery and various pediatric specialty clinics," she said.
In one child with severe epilepsy, the task force used sequencing of the protein-coding regions of the genome (about 2% of the entire human genome) to identify a broken gene that impairs the ability of sodium to move in and out of cells.
"We determined that the child's condition was caused by a new mutation in a gene named SCN2A," Dr. Davis said.
Read more:
DNA sequencing of infants and children with anatomical defects of unknown causes
Public release date: 6-Nov-2012 [ | E-mail | Share ]
Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics
A multi-institutional team of researchers has sequenced the DNA of 6,700 exomes, the portion of the genome that contains protein-coding genes, as part of the National Heart, Lung and Blood Institute (NHLBI)-funded Exome Sequencing Project, one of the largest medical sequencing studies ever undertaken.
Scientists participating in the project initially expected that individual rare variants would have a greater effect on over 80 heart, lung and blood related traits and diseases of high public health significance, said Suzanne M. Leal, Ph.D., professor and director, Center for Statistical Genetics in the Department of Molecular and Human Genetics of Baylor College of Medicine in Houston, TX.
The researchers found that many (1.1 million) of the 1.2 million coding variants that they identified in exome data from 4,420 European-Americans and 2,312 African-Americans occurred very infrequently in the population and often were only observed in a single individual, explained Dr. Leal, who presented the findings today at the American Society of Human Genetics 2012 meeting.
Dr. Leal added that most of the observed coding variants are population specific, occurring in either European or African Americans. "Of the identified variants, about 720,000 change the genetic code in a manner that could produce flawed proteins. Yet the role played by most of these variants in disease development has not been established," she said.
The major goal of the project was to understand how variation in the exome affects heart, lung and blood related traits and diseases.
The study participants were selected from a sample of over 220,000 individuals who participated in another National Institute of Health (NIH) supported study that had collected extensive medical data on the participants. "Individuals were selected to have a disease endpoint of interest or an extreme trait value of public health importance," said Dr. Leal.
By sequencing the exomes of 91 cystic fibrosis patients, Dr. Leal and her research colleagues discovered and replicated an association between variants in the DCTN4 gene and when a patient first develops a Pseudomonas aeruginosa airway infection.*
The researchers were also able to replicate many known associations between individual DNA variants and traits, such as high blood levels of low-density lipoprotein, known as the 'bad' cholesterol, and C-reactive protein, which increases the body's response to inflammation.
More:
Surprising findings from NHLBI Exome Sequencing Project reported
Public release date: 6-Nov-2012 [ | E-mail | Share ]
Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics
Scientists have adopted a novel laboratory approach for determining the effect of genetic variation on the efficiency of the biological process that translates a gene's DNA sequence into a protein, such as hemoglobin, according to a presentation, Nov. 6, at the American Society of Human Genetics 2012 meeting in San Francisco.
In the 0.1% of the DNA that differs between any two individuals, scientists search for the biological mechanisms underlying human genetic differences, including disease susceptibility.
"How exactly these slight changes in the DNA affect the biology of the human body is not known in most cases," said Constantin Polychronakos, M.D., professor of pediatrics, experimental medicine and human genetics at McGill University, Montreal, Canada.
"We decided to investigate the possibility that some of these changes may alter the translation of RNA into protein, a question that had not been systematically examined before," he added.
Translation is the final stage of gene expression at which the gene's DNA recipe for a protein can be modified, said McGill University scientist Quan Li, Ph.D., who presented the research.
In general, genomic studies have focused on finding links between diseases and variation in DNA. However, the new study takes a big step toward understanding how that variation affects the production of proteins, which are the molecules that most directly affect health and disease.
The study was designed to determine the effect of single-nucleotide polymorphisms (SNPs), which are variations in the DNA sequence, on the process of translation, Dr. Li said.
Translation begins when a gene's DNA sequence is transcribed into the messenger RNA (mRNA) molecule that carries the transcript, or the blueprint for the protein encoded by the gene, to ribosomes, where proteins are manufactured in a cell.
See more here:
New method helps link genomic variation to protein production
Public release date: 6-Nov-2012 [ | E-mail | Share ]
Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics
Humans share over 90% of their DNA with their primate cousins. The expression or activity patterns of genes differ across species in ways that help explain each species' distinct biology and behavior.
DNA factors that contribute to the differences were described on Nov. 6 at the American Society of Human Genetics 2012 meeting in a presentation by Yoav Gilad, Ph.D., associate professor of human genetics at the University of Chicago.
Dr. Gilad reported that up to 40% of the differences in the expression or activity patterns of genes between humans, chimpanzees and rhesus monkeys can be explained by regulatory mechanisms that determine whether and how a gene's recipe for a protein is transcribed to the RNA molecule that carries the recipe instructions to the sites in cells where proteins are manufactured.
In addition to improving scientific understanding of the uniqueness of humans, studies such as the investigation conducted by Dr. Gilad and colleagues could have relevance to human health and disease.
"Through inter-species' comparisons at the DNA sequence and expression levels, we hope to identify the genetic basis of human specific traits and in particular the genetic variations underlying the higher susceptibility to certain diseases such as malaria and cancer in humans than in non-human primates," said Dr. Gilad.
Dr. Gilad and his colleagues studied gene expression in lymphoblastoid cell lines, laboratory cultures of immortalized white blood cells, from eight humans, eight chimpanzees and eight rhesus monkeys.
They found that the distinct gene expression patterns of the three species can be explained by corresponding changes in genetic and epigenetic regulatory mechanisms that determine when and how a gene's DNA code is transcribed to a messenger RNA (mRNA) molecule.
Dr. Gilad also determined that the epigenetics process known as histone modification also differs in the three species. The presence of histone marks during gene transcription indicates that the process is being prevented or modified.
Go here to see the original:
Humans, chimpanzees and monkeys share DNA but not gene regulatory mechanisms
MEAT SHIELD (The Hidden)
#9658; #9658; #9658; Enjoy the video? Subscribe! bit.ly #9668; #9668; #9668; Download Here: http://www.hidden-source.com What is The Hidden? "In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies. The subject was left in constant pain and with unstable DNA. The subject escaped captivity, killing anyone that got in its way. The IRIS (Infinitum Research Interception Squad) team have been deployed to return the subject to a maximum security Infinitum Research facility for further study and dissection. The entire project was considered a failure: all funding ceased and development was discontinued while all records and traces of the experiments ...From:SeaNannersViews:96656 0ratingsTime:03:31More inGaming
Continued here:
GHOST DANCE (The Hidden) !
Download full: ftpgood.com What is The Hidden? "In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage: Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies. The subject was left in constant pain and with unstable DNA. The subject escaped captivity, killing anyone that got in its way. The IRIS (Infinitum Research Interception Squad) team have been deployed to return the subject to a maximum security Infinitum Research facility for further study and dissection. The entire project was considered a failure: all funding ceased and development was discontinued while all records and traces of the experiments were destroyed. Infinitum Research denies all knowledge of ...From:EssieZoucks6Views:0 0ratingsTime:04:02More inEntertainment
See the article here:
Neil Risch - Wiki Article
Neil Risch is an American human geneticist and professor at the University of California, San Francisco (UCSF). Risch is the Lamond Family Foundation Distinguished Professor in Human Genetics and Dir... Neil Risch - Wiki Article - wikiplays.org Original @ http All Information Derived from Wikipedia using Creative Commons License: en.wikipedia.org Author: Unknown Image URL: en.wikipedia.org Licensed under:Creative Commons ASA 3.0, This work is in the public domain in the United States.From:WikiPlaysViews:0 0ratingsTime:03:49More inEducation
Read more from the original source:
Public release date: 31-Oct-2012 [ | E-mail | Share ]
Contact: Mary Rice mary.rice@riceconseil.eu European Society of Human Genetics
In response to the on-line publication by the European Journal of Human Genetics today (Wednesday) of an article by US researchers led by Dr. Robert Cook-Degan, a former member of the US Office of Technology Assessment, showing that Myriad Genetics, providers of the BRCA1/2 genetic test in the US, has amassed vast quantities of clinical data without sharing it, Professor Martina Cornel, chair of the European Society of Human Genetics' Professional and Public Policy committee, said:
"We are very concerned that such important data is being withheld from those who most need it. Interpreting the variants of unknown significance (VUS) that may be found on analysing the patient's genome plays an essential part in being able to provide proper counselling and if necessary, preventive or therapeutic guidance. By not sharing their data on the VUS obtained from individuals undergoing BRCA1/2 testing, where Myriad is the sole commercial provider of a test in the US, geneticists have been unable to develop the up-to-date algorithms that are necessary to best interpret the effects of genetic variants. While Myriad has access to public databases in order to help interpret their VUS results, this is currently not reciprocal.
"We know that, regrettably, medical geographic inequities are common, but what is particularly worrying about this situation is that it is the first time that such inequities have been based on a lack of access to clinical information, rather than lack of a product. Myriad's stated aim to enter the European market more vigorously may lead to unfair competition with academic institutions for predictive precision. It is vital that progress towards personalised medicine, which holds out so much promise, is not hindered by companies maintaining private genomic databases. Policymakers should take an urgent look at the regulatory and reimbursement issues involved in genomic testing in order for all the data that is essential to understanding the clinical significance of VUS to be made public, to the benefit of patients and healthcare providers alike."
###
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
More here:
Human Genetics - The Cell Cycle
From:BoyneatBradfordViews:27 0ratingsTime:51:56More inEducation
Originally posted here:
Human Genetics - Mitosis and Meiosis
From:BoyneatBradfordViews:41 0ratingsTime:37:58More inEducation
Excerpt from:
A Conversation with Luigi Luca Cavalli-Sforza
In this interview for the Annual Review of Genomics and Human Genetics, Dr. Luigi Luca Cavalli-Sforza talks with Dr. Anne Bowcock about his life and career in the field of human population genetics. Dr. Cavalli-Sforza discusses his work studying specific populations of people in Parma, Italy, using the parish books of local communities, as well as his work on the Human Genome Diversity Project. Dr. Cavalli-Sforza wrote a related article for the Annual Review of Genomics and Human Genetics titled "Human Evolution and Its Relevance for Genetic Epidemiology." Read the article online: http://www.annualreviews.orgFrom:annualreviewsViews:37 0ratingsTime:21:02More inScience Technology
See the rest here:
Hidden part 1 w/ Zerox And Friends : JUSTICE!
In the early 1950s human genetics experimentation was taking its first, tentative steps. Amongst many other black projects, a team of British scientists working at an Infinitum Research experimental station stumbled across some remarkable phenomena involving DNA manipulation. This led to deeper research with dangerously unpredictable results, often leading to human patients losing their lives in irresponsible and immoral experiments. Time passed on, and by the mid 1990s the failure rate of the experiments had been reduced from 75% to a mere 15%, enough for Infinitum to move onto the next stage: Biological Light Refraction. The British team were hoping to unravel the possibilities of light manipulation to create the perfect covert military agent. Early into the new millennium, due to a gross miscalculation, a series of tests on Subject 617 led to a massive synaptic trauma leaving the patient with multiple genetic anomalies. The subject was left in constant pain and with unstable DNA. The subject escaped captivity, killing anyone that got in its way. The IRIS (Infinitum Research Interception Squad) team have been deployed to return the subject to a maximum security Infinitum Research facility for further study and dissection. The entire project was considered a failure: all funding ceased and development was discontinued while all records and traces of the experiments were destroyed. Infinitum Research denies all knowledge of any form of human DNA manipulation but are more ...From:xXZeroxGamersXxViews:5 2ratingsTime:30:45More inGaming
View post:
Control of Humanity The Nephilim
Alternative historian Michael Tsarion discussed humankind #39;s future and the "ancient alien agenda," as carried out by unseen elite or controllers. Aliens or #39;Nephilim #39; were scientists who lost their technology during a great war 13000 years ago, but it is now being restored, he claimed. This new wave of technology, will follow in the footsteps of Silicon Valley and the computer revolution, yet be presented as a spiritual step forward to the masses, he cautioned. Mankind has been traumatized at various stages, and human consciousness was damaged, such as when the Nephilim tinkered with human genetics, Tsarion explained. This damage makes people more susceptible to being controlled, he noted. The elite plan to further "dumb down" humanity to the level of machines, so that their thinking is mechanical-- this creates the perfect slave, he continued. Tsarion also touched on his work with astro-theology, and astrological significances. We are seeing the down side of the Age of Aquarius or awakening, with Uranian energy emerging that upsets current structures, and causes people to feel insecure or uncertain as old paradigms pass away, he commented. Biography: Alternative historian and author, Michael Tsarion is an expert on the occult history of Ireland and America. Born in Ireland, he has researched mythologies of the world, as well as his own country #39;s magnificent and mysterious Druidic history. Michael #39;s work considers the consequences to civilization of extraterrestrial ...From:DiscloseTruthTVViews:549 12ratingsTime:01:10:24More inEducation
Continued here:
Learn anatomy and physiology
howtowordpressplugins.com Lesson 1: Introduction to Basic Human Physiology Lesson 2: Physiology of Cells and Miscellaneous Tissues Lesson 3: Envelopes of the Body Lesson 4: The Skeletal System Lesson 5: Physiology and Actions of Muscles Lesson 6: The Human Digestive System Lesson 7: The Human Respiratory System and Breathing Lesson 8: The Human Urinary System Lesson 9: The Human Reproductive (Genital) System Lesson 10: Cardiovascular and Other Circulatory Systems of the Human Body Lesson 11: The Human Endocrine System Lesson 12: The Human Nervous System Lesson 13: The Special Senses Lesson 14: Some Elementary Human Genetics Ear-Eyes-Nose Injuries Musculoskeletal System Nursing Care Related to the Musculoskeletal System Anatomy and Physiology Related to Clinical Pathology AND MANY MORE!From:mark bredahlViews:2 0ratingsTime:01:53More inEducation
Link:
Human Genetics - Genetic Variation podcast
From:BoyneatBradfordViews:26 0ratingsTime:58:43More inEducation
Read this article:
Human Genetics - Single Gene Disorders podcast
From:BoyneatBradfordViews:21 0ratingsTime:49:16More inEducation
Go here to see the original: